Invention Grant
US08268812B2 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
有权
使用恶唑烷酮 - 喹啉杂合抗生素治疗炭疽和其他感染
- Patent Title: Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
- Patent Title (中): 使用恶唑烷酮 - 喹啉杂合抗生素治疗炭疽和其他感染
-
Application No.: US12987611Application Date: 2011-01-10
-
Publication No.: US08268812B2Publication Date: 2012-09-18
- Inventor: Christian Hubschwerlen , Jean-Luc Specklin , Daniel Baeschlin , Hans Locher , Christine Schmitt
- Applicant: Christian Hubschwerlen , Jean-Luc Specklin , Daniel Baeschlin , Hans Locher , Christine Schmitt
- Applicant Address: DE Munich
- Assignee: Morphochem Aktiengesellschaft fül Kombinatorische Chemie
- Current Assignee: Morphochem Aktiengesellschaft fül Kombinatorische Chemie
- Current Assignee Address: DE Munich
- Agency: Edwards Wildman Palmer LLP
- Agent Christine C. O'Day; Nicholas J. DiCeglie, Jr.
- Main IPC: A61K31/00
- IPC: A61K31/00 ; A61K31/47 ; A61K31/445 ; A61K31/42
Abstract:
The present invention relates to the use of compounds, in which the pharmacophores of quinolone and oxazolidinone are chemically linked together through a linker that is stable under physiological conditions, for the treatment of anthrax and other infections.
Public/Granted literature
- US20120135961A1 USE OF OXAZOLIDINONE-QUINOLINE HYBRID ANTIBIOTICS FOR THE TREATMENT OF ANTHRAX AND OTHER INFECTIONS Public/Granted day:2012-05-31
Information query
